36.—(1) A licensee must implement effective measures to ensure that every patient receives accurate, complete and timely information about the patient’s care and treatment.
[S 414/2023 wef 26/06/2023]
(2) A licensee must establish and implement an appropriate system for obtaining the consent of a patient for any medical procedure that is carried out, or to be carried out, in the provision of the licensable healthcare service, and maintaining a proper record of the consent obtained.
[S 414/2023 wef 26/06/2023]
(3) Where, in the provision of a licensable healthcare service by a licensee, a test is conducted (whether or not by the licensee) on a patient who is under the direct care of the licensee, the licensee must ensure all of the following:
(a)
the findings of the test are brought to the attention of the requestor without undue delay;
[S 414/2023 wef 26/06/2023]
(b)
the requestor reviews the findings in a timely manner;
[S 414/2023 wef 26/06/2023]
(c)
the patient is informed, without undue delay, of the findings that, in the professional opinion of the requestor, are clinically significant;
[S 414/2023 wef 26/06/2023]
(d)
the requestor advises the patient, based on the findings and without undue delay, on the patient’s condition, prognosis and clinical management.
[S 414/2023 wef 26/06/2023]
[S 414/2023 wef 26/06/2023]
(4) In this regulation, “requestor”, in relation to a test conducted on a patient, means —
(a)
the medical practitioner, dentist or collaborative prescribing practitioner who ordered the test for the patient; and
(b)
any medical practitioner, dentist or collaborative prescribing practitioner designated by the person mentioned in sub-paragraph (a) to carry out any duty mentioned in paragraph (3)(a), (b), (c) or (d).